{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+%28Part+II%29&page=6", "query": { "intervention": "Placebo (Part II)", "page": 6 }, "page_size": 10 }, "pagination": { "page": 6, "page_size": 10, "total_count": 146, "total_pages": 15, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+%28Part+II%29&page=7&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+%28Part+II%29&page=5&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T11:17:25.981Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02010203", "title": "A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Bladder Cancer" ], "interventions": [ { "name": "HS-410", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "BCG", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Heat Biologics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 104, "start_date": "2013-12", "completion_date": "2018-04", "has_results": true, "last_update_posted_date": "2020-02-17", "last_synced_at": "2026-11-15T11:17:25.981Z", "location_count": 19, "location_summary": "Los Angeles, California • Sherman Oaks, California • Torrance, California + 16 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Sherman Oaks", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02010203" }, { "nct_id": "NCT05844735", "title": "A Randomized Placebo- and Active Comparator-controlled Study to Evaluate the Photosafety of SAR441566", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "SAR441566", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Ciprofloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 60, "start_date": "2023-05-22", "completion_date": "2023-10-23", "has_results": false, "last_update_posted_date": "2025-09-16", "last_synced_at": "2026-11-15T11:17:25.981Z", "location_count": 1, "location_summary": "Fair Lawn, New Jersey", "locations": [ { "city": "Fair Lawn", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05844735" }, { "nct_id": "NCT05162586", "title": "The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Systemic Lupus Erythematosus" ], "interventions": [ { "name": "Enpatoran low dose", "type": "DRUG" }, { "name": "Enpatoran medium dose", "type": "DRUG" }, { "name": "Enpatoran high dose", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "EMD Serono Research & Development Institute, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 456, "start_date": "2022-03-31", "completion_date": "2024-11-20", "has_results": true, "last_update_posted_date": "2025-12-01", "last_synced_at": "2026-11-15T11:17:25.981Z", "location_count": 14, "location_summary": "Torrance, California • Brandon, Florida • Miami, Florida + 10 more", "locations": [ { "city": "Torrance", "state": "California" }, { "city": "Brandon", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami Lakes", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05162586" }, { "nct_id": "NCT00613626", "title": "Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Small Cell Lung Cancer" ], "interventions": [ { "name": "Cisplatin", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "ZD6474", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoosier Cancer Research Network", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 74, "start_date": "2008-01", "completion_date": "2015-08", "has_results": true, "last_update_posted_date": "2020-02-11", "last_synced_at": "2026-11-15T11:17:25.981Z", "location_count": 19, "location_summary": "Newark, Delaware • Chicago, Illinois • Galesburg, Illinois + 13 more", "locations": [ { "city": "Newark", "state": "Delaware" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Galesburg", "state": "Illinois" }, { "city": "Bloomington", "state": "Indiana" }, { "city": "Evansville", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00613626" }, { "nct_id": "NCT01448200", "title": "A Phase 1 Study of PPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hepatitis C, Chronic" ], "interventions": [ { "name": "PPI-668", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Presidio Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 82, "start_date": "2011-10", "completion_date": "2012-11", "has_results": false, "last_update_posted_date": "2012-11-16", "last_synced_at": "2026-11-15T11:17:25.981Z", "location_count": 4, "location_summary": "Costa Mesa, California • Sacramento, California • San Francisco, California + 1 more", "locations": [ { "city": "Costa Mesa", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01448200" }, { "nct_id": "NCT01900431", "title": "Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Uveitis" ], "interventions": [ { "name": "Sarilumab", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Folic/folinic acid", "type": "DRUG" }, { "name": "Placebo (for Sarilumab)", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 58, "start_date": "2013-10", "completion_date": "2016-04", "has_results": true, "last_update_posted_date": "2017-06-20", "last_synced_at": "2026-11-15T11:17:25.981Z", "location_count": 5, "location_summary": "Worcester, Massachusetts • Omaha, Nebraska • Slingerlands, New York + 2 more", "locations": [ { "city": "Worcester", "state": "Massachusetts" }, { "city": "Omaha", "state": "Nebraska" }, { "city": "Slingerlands", "state": "New York" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Arlington", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01900431" }, { "nct_id": "NCT02665143", "title": "A Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Relapsed/Refractory Acute Myeloid Leukemia" ], "interventions": [ { "name": "Nintedanib and AML induction", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2016-07-21", "completion_date": "2021-03-30", "has_results": true, "last_update_posted_date": "2022-04-08", "last_synced_at": "2026-11-15T11:17:25.981Z", "location_count": 2, "location_summary": "New Haven, Connecticut • Nashville, Tennessee", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02665143" }, { "nct_id": "NCT00031720", "title": "Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer", "Hot Flashes", "Hot Flushes" ], "interventions": [ { "name": "soy protein", "type": "DIETARY_SUPPLEMENT" }, { "name": "isoflavones", "type": "DIETARY_SUPPLEMENT" }, { "name": "Tamoxifen", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "DRUG", "OTHER" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 112, "start_date": "2002-03", "completion_date": "2013-11", "has_results": false, "last_update_posted_date": "2016-07-13", "last_synced_at": "2026-11-15T11:17:25.981Z", "location_count": 14, "location_summary": "Rockford, Illinois • Elkhart, Indiana • Kokomo, Indiana + 9 more", "locations": [ { "city": "Rockford", "state": "Illinois" }, { "city": "Elkhart", "state": "Indiana" }, { "city": "Kokomo", "state": "Indiana" }, { "city": "La Porte", "state": "Indiana" }, { "city": "South Bend", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00031720" }, { "nct_id": "NCT01119846", "title": "A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "GSK1292263", "type": "DRUG" }, { "name": "GSK1292263 matching placebo", "type": "DRUG" }, { "name": "Sitagliptin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 100, "start_date": "2009-06-05", "completion_date": "2010-03-19", "has_results": true, "last_update_posted_date": "2018-01-17", "last_synced_at": "2026-11-15T11:17:25.981Z", "location_count": 7, "location_summary": "Phoenix, Arizona • Chula Vista, California • Miami, Florida + 4 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01119846" }, { "nct_id": "NCT07112872", "title": "A Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Tifeglipron", "type": "DRUG" }, { "name": "Semaglutide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 330, "start_date": "2025-08-19", "completion_date": "2028-02-05", "has_results": false, "last_update_posted_date": "2026-11-12", "last_synced_at": "2026-11-15T11:17:25.981Z", "location_count": 24, "location_summary": "Tucson, Arizona • Lake Forest, California • Rancho Cucamonga, California + 21 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Lake Forest", "state": "California" }, { "city": "Rancho Cucamonga", "state": "California" }, { "city": "Spring Valley", "state": "California" }, { "city": "Waterbury", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT07112872" } ] }